Beijing Tiantan Biological Products Co., Ltd. (SHA: 600161)

Beijing Tiantan Biological Products Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	43,561	50,983	39,103	39,767	52,310	29,208
Market Cap Growth	17.71%	30.38%	-1.67%	-23.98%	79.10%	57.78%
Enterprise Value	42,003	49,023	37,846	37,744	52,384	29,158
Last Close Price	22.03	25.65	19.64	19.89	28.56	15.93
PE Ratio	34.53	45.94	44.39	52.32	81.86	47.80
Forward PE	31.68	39.63	39.14	45.04	67.68	37.76
PS Ratio	8.41	9.84	9.18	9.67	15.18	8.90
PB Ratio	4.09	4.00	3.44	3.87	8.67	5.64
P/TBV Ratio	5.11	5.69	4.78	5.27	12.60	8.27
P/FCF Ratio	161.44	38.74	-	-	561.25	251.27
P/OCF Ratio	36.79	21.30	34.73	40.56	74.50	45.46
PEG Ratio	0.62	0.62	0.62	0.62	0.62	0.62
EV/Sales Ratio	8.03	9.46	8.88	9.18	15.20	8.88
EV/EBITDA Ratio	18.09	25.12	26.07	28.75	44.33	25.36
EV/EBIT Ratio	21.10	28.73	29.27	32.15	49.94	28.55
EV/FCF Ratio	155.67	37.25	-	-	562.04	250.85
Debt / Equity Ratio	0.00	0.00	0.04	0.05	0.13	0.08
Debt / EBITDA Ratio	0.02	0.02	0.27	0.38	0.68	0.35
Debt / FCF Ratio	0.15	0.03	-	-	8.59	3.45
Asset Turnover	0.35	0.38	0.35	0.43	0.50	0.58
Inventory Turnover	0.80	0.99	0.97	1.00	0.85	0.91
Quick Ratio	3.28	3.66	4.25	6.64	2.62	3.18
Current Ratio	5.51	5.92	6.28	9.32	4.96	6.21
Return on Equity (ROE)	13.14%	12.52%	11.14%	13.12%	16.83%	18.78%
Return on Assets (ROA)	8.25%	7.86%	6.60%	7.68%	9.46%	11.22%
Return on Capital (ROIC)	9.36%	8.69%	7.17%	8.33%	10.56%	12.57%
Earnings Yield	2.90%	2.18%	2.25%	1.91%	1.22%	2.09%
FCF Yield	0.62%	2.58%	-0.58%	-0.38%	0.18%	0.40%
Dividend Yield	0.57%	0.49%	0.21%	0.35%	0.24%	0.22%
Payout Ratio	19.50%	8.47%	17.85%	21.56%	14.54%	9.88%
Buyback Yield / Dilution	-1.32%	0.32%	-2.79%	-7.41%	-0.59%	0.04%
Total Shareholder Return	-0.75%	0.81%	-2.58%	-7.06%	-0.35%	0.26%

Source: S&P Capital IQ. Standard template. Financial Sources.